Details of the Drug

General Information of Drug (ID: DMZONKL)

Drug Name

131I-CLR-1404

Synonyms

NM-324; CLR-1404-[124I]; CLR-1404-[125I]; CLR-1404-[131I]; NM-404-[124I]; NM-404-[125I]; NM-404-[131I]; NM-412-[125I]; Radiolabeled phospholipid ether (cancer), Cellectar; Small molecule phospholipid ether analogs (cancer imaging), University of Michigan; Iodine-124-CLR-1404; Iodine-124-NM-404; Iodine-125-CLR-1404; Iodine-125-NM-404; Iodine-125-NM-412; Iodine-131-CLR-1404; Iodine-131-NM-404; 124I-CLR-1404; 124I-NM-404; 125I-CLR-1404; 125I-NM-404; 125I-NM-412

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D Structure is Not Available

3D MOL

2D MOL

Cross-matching ID

TTD ID: D03NMQ

References

1	ClinicalTrials.gov (NCT01898273) Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma. U.S. National Institutes of Health.